department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Gan & Lee Pharmaceuticals Co Ltd · pharmadog

PUBLIC COMPANY

Gan & Lee Pharmaceuticals Co Ltd

updated 1mo ago

community read0 votes

pipeline

6

marketed

0

phase 3

0

catalysts ytd

3

approvals ytd

0

recalls ytd

0

Pipeline(6)

pipeline depth6 products

1Preclinical1Phase 23pre_registration1Unknown

Malignant Glioma

pre_registration

Type 1 Diabetes (Juvenile Diabetes)

Insulin receptor

pre_registration

insulin glargine LA

Type 1 Diabetes (Juvenile Diabetes)

Insulin receptor

Upcoming

no upcoming catalysts on record

Recent(90d)

phase 1 initiation (1) · phase 3 initiation (2)

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Gan & Lee Pharmaceuticals Co Ltd jobs →

News

no news has mentioned this company yet

identifiers

source

globaldata

top tags

Obesity1 Oncology1

mentioned in

0news items

entity-linker matched

pre_registration

Type 1 Diabetes (Juvenile Diabetes)

Insulin receptor

phase 1 initiation

Gan & Lee Pharmaceuticals Co Ltd — GLR-2037 (Phase I Trial Initiation)

phase 3 initiation

Gan & Lee Pharmaceuticals Co Ltd — (insulin aspart + insulin aspart protamine) (Phase III Trial Initiation)

(insulin aspart + insulin aspart protamine)

phase 3 initiation

Gan & Lee Pharmaceuticals Co Ltd — bofanglutide (Phase III Trial Initiation)

Active trials

phase2Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetesnot yet recruitingn=345
phase3Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetesnot yet recruitingn=350
phase3Evaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Receiving Positive Airway Pressure (PAP) Therapynot yet recruitingn=140
phase3Evaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Not Treated With Positive Airway Pressure (PAP) Therapynot yet recruitingn=140
phase1A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancernot yet recruitingn=65
phase3Extension Study of the Phase 3 Clinical Study of GZR18 Injection for Weight Lossrecruitingn=500
phase1Bioequivalence Study of GZR18 Injection Before and After CMC Changerecruitingn=138
phase1A Study to Evaluate the Biosimilarity of GLR1044 Injection and Dupilumab Injection (Dupixent®) in Healthy Adult Male Subjectsnot yet recruitingn=198

more trials →

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 8

tagOncology2 co-mentions · 1 sources
tagType 2 Diabetes2 co-mentions · 1 sources
druginsulin aspart2 co-mentions · 1 sources
drugFiasp2 co-mentions · 1 sources
druginsulin2 co-mentions · 1 sources
tagPulmonology1 co-mentions · 1 sources
tagEndocrinology & Metabolism1 co-mentions · 1 sources
tagProstate Cancer1 co-mentions · 1 sources